Category: Cost and Quality

KHN’s ‘What the Health?’: The Autumn of Democrats’ Discontent

Congress is back in session with a short time to finish a long to-do list, including keeping the government operating and paying its bills. Hanging in the balance is President Joe Biden’s entire domestic agenda, including major changes proposed for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the new Texas abortion law that bans the procedure early in pregnancy is prompting action in Washington. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews former FDA Commissioner Scott Gottlieb about his new book on the covid-19 pandemic.

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?

Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.

‘An Arm and a Leg’: They Turned Grief Into Action

This episode highlights how New York enacted a charity care law, one of the precursors to the federal provision on charity care in the Affordable Care Act.  

The Solution to Au Pairs’ Health Coverage Gaps May Be Simple: ACA Plans

Private agencies that bring young adults to the U.S. to care for children generally offer basic health insurance, but plans may exclude many types of necessary care. What the agencies might not mention is that au pairs are eligible to enroll in comprehensive coverage on the Affordable Care Act marketplaces and likely qualify for premium subsidies that would make the insurance affordable.

KHN’s ‘What the Health?’: Much Ado About Drug Prices

Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.

Justice Department Targets Data Mining in Medicare Advantage Fraud Case

The feds’ civil suit links exaggerated patient bills to “tens of millions” in overcharges.

Why At-Home Rapid Covid Tests Cost So Much, Even After Biden’s Push for Lower Prices

Germans pay less than $1 per test. Brits get them free. Why do Americans pay so much more? Because companies can still demand it.

KHN’s ‘What the Health?’: The Future of Public Health

The covid pandemic has spotlighted the often-unseen role of public health in Americans’ daily lives. And the picture has not all been pretty. What is public health and why is it so important — and controversial? Dr. Ashish Jha, dean of the Brown University School of Public Health, explains the basics. Then, Joanne Kenen of Politico and Lauren Weber of KHN join KHN’s Julie Rovner to discuss what could happen next.

‘An Arm and a Leg’: How Charity Care Made It Into the ACA

In this episode, we hear how the political tango over guaranteeing that nonprofit hospitals provide charity care nearly tanked the Affordable Care Act — and how the battle over the ACA “broke America.”

Florida Spine Surgeon and Device Company Owner Charged in Kickback Scheme

Dr. Kingsley R. Chin and SpineFrontier were the subject of a recent KHN “Spinal Tap” investigation.